EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epstein–Barr virus (EBV) infection causes human germinal center B cell–derived lymphomas in the absence of EBNA2 expression

Chunyan Wang iD, Jillian A Bristol iD, Scott E Nelson iD, Tony Chen, Charlotte Hendrickson iD, Dana C Baiu, Mariah Riel, Mitch Hayes iD, Erik A Ranheim, Jenny E Gumperz iD, Eric C Johannsen iD, Shannon C Kenney iD

Proceedings of the National Academy of Sciences · 02.06.2026 · 123 (22)

DOI: 10.1073/pnas.2525164123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 26.05.2026. Verfasst von Chunyan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706. Hauptthemen laut MEDLINE: Epstein-Barr Virus Nuclear Antigens, Germinal Center, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EBV is associated with human B cell lymphomas, including Burkitt lymphomas (BLs), diffuse large B cell lymphomas (DLBCLs), Hodgkin lymphomas (HLs), and Plasmablastic lymphomas (PLs). EBV+ lymphomas in immunocompetent humans are usually derived from germinal center (GC)-experienced B cells and have stringent latency forms that do not express the viral transforming protein, EBNA2. Human EBV+ lymphomas that lack EBNA2 expression are largely driven by the viral LMP1 and LMP2A proteins, which activate NF-κB and B cell receptor-like signaling, respectively, or by Myc translocations. However, EBNA2 is required for EBV-mediated transformation of B cells in vitro and there is currently no model system for studying how EBV transforms human GC-derived B cells into lymphomas in vivo in the absence of EBNA2 expression or Myc translocation. Here, we show that human tonsil GC B cells (GCBs) infected with an EBNA2-deleted EBV mutant proliferate on a CD40L/IL21-expressing feeder layer and form lymphomas in NSG mice that resemble human DLBCLs (both ABC and GCB subtypes) and PLs. These EBV-induced lymphomas occur in the absence of Myc overexpression, often have normal karyotypes, and do not contain mutations in cellular genes (including p53) commonly mutated in uninfected human DLBCLs. Using this model system, we show that LMP2A induces plasmablast differentiation, increases expression of genes involved in lymphocyte mobility and trafficking and enhances tumor invasiveness in vivo. This new model system can thus be used to define roles of viral and cellular proteins in EBV-induced human GCB-derived lymphomas that lack EBNA2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus Nuclear AntigensGerminal CenterHerpesvirus 4, HumanEpstein-Barr Virus InfectionsViral ProteinsLymphoma, B-CellHumansAnimalsMiceB-LymphocytesCell Transformation, ViralViral Matrix ProteinsProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

DLBCLEBNA2EBVGC B cellLMP2A

Substanzen

Epstein-Barr Virus Nuclear AntigensEBNA-2 protein, Human herpesvirus 4Viral ProteinsEBV-associated membrane antigen, Epstein-Barr virusViral Matrix ProteinsProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706.
  • Department of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706.
  • Department of Pathology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706.
  • Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706.

ORCID-Profile: Chunyan Wang, Jillian A Bristol, Scott E Nelson, Charlotte Hendrickson, Mitch Hayes, Jenny E Gumperz, Eric C Johannsen, Shannon C Kenney

Förderung

  • NCI NIH HHS
  • HHS | NIH (NIH)

Zitieren

APA

Wang, C., Bristol, J. A., Nelson, S. E., Chen, T., Hendrickson, C., Baiu, D. C., Riel, M., Hayes, M., Ranheim, E. A., Gumperz, J. E., Johannsen, E. C., & Kenney, S. C. (2026). Epstein–Barr virus (EBV) infection causes human germinal center B cell–derived lymphomas in the absence of EBNA2 expression. Proceedings of the National Academy of Sciences, 123(22). https://doi.org/10.1073/pnas.2525164123

Vancouver

Wang C, Bristol JA, Nelson SE, Chen T, Hendrickson C, Baiu DC, et al. Epstein–Barr virus (EBV) infection causes human germinal center B cell–derived lymphomas in the absence of EBNA2 expression. Proceedings of the National Academy of Sciences. 2026;123(22). doi:10.1073/pnas.2525164123

BibTeX
@article{Wang2026,
  author = {Wang, Chunyan and Bristol, Jillian A and Nelson, Scott E and Chen, Tony and Hendrickson, Charlotte and Baiu, Dana C and Riel, Mariah and Hayes, Mitch and Ranheim, Erik A and Gumperz, Jenny E and Johannsen, Eric C and Kenney, Shannon C},
  title = {Epstein–Barr virus (EBV) infection causes human germinal center B cell–derived lymphomas in the absence of EBNA2 expression},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {22},
  doi = {10.1073/pnas.2525164123}
}
Kostenlos starten →